Dinos Verouhis1, Peder Sörensson2, Andrey Gourine3, Loghman Henareh2, Jonas Persson4, Nawzad Saleh2, Magnus Settergren2, Martin Sundqvist5, Per Tornvall5, Nils Witt5, Felix Böhm2, John Pernow2. 1. Department of Medicine, Karolinska Institutet, and Department of Cardiology, Karolinska University Hospital. Electronic address: dinos.verouhis@karolinska.se. 2. Department of Medicine, Karolinska Institutet, and Department of Cardiology, Karolinska University Hospital. 3. Department of Medicine, Karolinska Institutet, and Department of Cardiology, Karolinska University Hospital; Research Centre Cardiology, Minsk, Belarus. 4. Division of Cardiovascular Medicine, Department of Clinical Sciences, Karolinska Institutet, Danderyd University Hospital. 5. Department of Clinical Science and Education, Karolinska Institutet, Södersjukhuset, Stockholm, Sweden.
Abstract
BACKGROUND: Previous studies indicate that remote ischemic conditioning performed before percutaneous coronary intervention (PCI) reduces infarct size in patients with ST-elevation myocardial infarction (STEMI). It remains unclear whether remote conditioning affords protection when performed in adjunct to primary PCI. We aimed to study whether remote ischemic per-postconditioning (RIperpostC) initiated after admission to the catheterization laboratory attenuates myocardial infarct size in patients with anterior STEMI. METHODS: In this prospective multicenter trial 93 patients with anterior STEMI were randomized to RIperpostC or sham procedure as adjunct to primary PCI. RIperpostC was started on arrival in the catheterization laboratory by 5-minute cycles of inflation and deflation of a blood pressure cuff around the left thigh and continued throughout the PCI procedure. Infarct size and myocardium at risk were determined by cardiac magnetic resonance at day 4 to 7. The primary outcome was myocardial salvage index. RESULTS: There was no significant difference in myocardial salvage index between the RIperpostC and control group (median 48.5% and interquartile range 30.9%-60.8% vs 49.2% [42.1%-58.8%]). Neither did absolute infarct size in relation to left ventricular myocardial volume differ significantly (RIperpostC 20.6% [14.1%-31.7%] vs control 17.9% [13.4%-25.0%]). The RIperpostC group had larger myocardial area at risk than the control group (43.1% (35.4%-49.7%) vs 37.0% (30.8%-44.1%) of the left ventricle, P=.03). Peak value and area under the curve for troponin T did not differ significantly between the study groups. CONCLUSIONS: RIperpostC initiated after admission to the catheterization laboratory in patients with anterior STEMI did not confer protection against reperfusion injury.
RCT Entities:
BACKGROUND: Previous studies indicate that remote ischemic conditioning performed before percutaneous coronary intervention (PCI) reduces infarct size in patients with ST-elevation myocardial infarction (STEMI). It remains unclear whether remote conditioning affords protection when performed in adjunct to primary PCI. We aimed to study whether remote ischemic per-postconditioning (RIperpostC) initiated after admission to the catheterization laboratory attenuates myocardial infarct size in patients with anterior STEMI. METHODS: In this prospective multicenter trial 93 patients with anterior STEMI were randomized to RIperpostC or sham procedure as adjunct to primary PCI. RIperpostC was started on arrival in the catheterization laboratory by 5-minute cycles of inflation and deflation of a blood pressure cuff around the left thigh and continued throughout the PCI procedure. Infarct size and myocardium at risk were determined by cardiac magnetic resonance at day 4 to 7. The primary outcome was myocardial salvage index. RESULTS: There was no significant difference in myocardial salvage index between the RIperpostC and control group (median 48.5% and interquartile range 30.9%-60.8% vs 49.2% [42.1%-58.8%]). Neither did absolute infarct size in relation to left ventricular myocardial volume differ significantly (RIperpostC 20.6% [14.1%-31.7%] vs control 17.9% [13.4%-25.0%]). The RIperpostC group had larger myocardial area at risk than the control group (43.1% (35.4%-49.7%) vs 37.0% (30.8%-44.1%) of the left ventricle, P=.03). Peak value and area under the curve for troponin T did not differ significantly between the study groups. CONCLUSIONS:RIperpostC initiated after admission to the catheterization laboratory in patients with anterior STEMI did not confer protection against reperfusion injury.
Authors: Bruno García Del Blanco; Imanol Otaegui; José F Rodríguez-Palomares; Antoni Bayés-Genis; Eduard Fernández-Nofrerías; Victoria Vilalta Del Olmo; Xavier Carrillo; Borja Ibáñez; Fernando Worner; Juan Casanova; Eva Pueo; Jose R González-Juanatey; Javier López-Pais; Alfredo Bardají; Gil Bonet; Mónica Fuertes; Antonio Rodríguez-Sinovas; Marisol Ruiz-Meana; Javier Inserte; Ignasi Barba; Sandra Gómez-Talavera; Gerard Martí; Bernat Serra; Neus Bellera; Manuel Ojeda-Ramos; Hug Cuellar; Filipa Valente; Maria Ángeles Carmona; Elisabet Miró-Casas; Josep R Marsal; Antonia Sambola; Rosa M Lidón; Jordi Bañeras; Jaime Elízaga; Ferran Padilla; José A Barrabés; Derek J Hausenloy; Ignacio Ferreira-González; David García-Dorado Journal: Basic Res Cardiol Date: 2021-01-25 Impact factor: 17.165
Authors: J Ranjit Arnold; Andrew P Vanezis; Glenn C Rodrigo; Florence Y Lai; Prathap Kanagala; Sheraz Nazir; Jamal N Khan; Leong Ng; Kamal Chitkara; J Gerry Coghlan; Simon Hetherington; Nilesh J Samani; Gerald P McCann Journal: Basic Res Cardiol Date: 2022-04-23 Impact factor: 12.416